The Immunomodulation Effect of Blood Transfusion in Operative Spine Surgery Patients

NCT02069210 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 40

Last updated 2014-02-24

No results posted yet for this study

Summary

The purpose of this study is to investigate the effect of transfusion of allogeneic (homologous) red cells on the immunologic parameters such as T-cells as well as natural killer cell count/function, various interleukins, TNF alpha and other immunologic relevant parameters on postoperative day 1,3 and 5-7 in patients undergoing spine surgery.

Conditions

  • Infection After Transfusion

Interventions

OTHER

Blood transfusion

Intraoperative blood transfusion

Sponsors & Collaborators

  • Wolf-Schleinzer-Stiftung

    collaborator UNKNOWN
  • Mahidol University

    lead OTHER

Principal Investigators

  • Sirilak Suksompong, MD · Department of Anesthesiology, Faculty of medicine Siriraj Hospital, Mahidol University

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-05-31
Primary Completion
2015-12-31
Completion
2015-12-31

Countries

  • Thailand

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02069210 on ClinicalTrials.gov